Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  British American Tobacco    BATS   GB0002875804

BRITISH AMERICAN TOBACCO

(BATS)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

British American Tobacco : In crackdown, U.S. FDA seeks details on new electronic cigarettes

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/12/2018 | 12:34pm EST
FILE PHOTO: A young man smokes a Suorin Drop electronic cigarette in this picture illustration

LOS ANGELES (Reuters) - Faced with a proliferation of new electronic cigarettes and a sharp rise in teen vaping, the U.S. Food and Drug Administration on Friday sent letters to 21 electronic cigarette manufacturers seeking information to assess whether the products are being marketed illegally.

An FDA rule banned the sale of new e-cigarette products after August 2016 without regulatory approval. In September, Reuters reported that startups and big tobacco firms launched more than a dozen new high-nicotine e-cigarette products mimicking the popular Juul devices after the FDA imposed the deadline.

The agency on Friday sent letters to companies including Reynolds American Inc, a unit of British American Tobacco Plc, which makes the Vuse Alto device, asking for evidence that the products were on the market before the August 2016 cutoff.

FDA Commissioner Scott Gottlieb said the agency "will not allow the proliferation of e-cigarettes" being sold without proper approval.

The agency also sent letters to Fontem Ventures, a unit of Imperial Brands Plc, seeking information about its myblu e-cigarettes, as well as smaller companies including Kandypens, Myle Vapor and VGOD.

Shares of British American Tobacco on Friday were down 3.9 percent and Imperial Brands fell 6 percent in London.

A spokesman for British American Tobacco said the company will provide to the FDA information to show it is in compliance with the rule. He said the company notified the FDA in May that the product was a "repackaged and re-branded" version of a product that was on the market before August 2016.

A spokesman for Imperial Brands said the myblu products are in compliance with FDA rules, adding that the company will provide the requested documentation soon.

Representatives for the other companies did not respond to requests for comment.

If the FDA determines the e-cigarettes were introduced after the August 2016 deadline, companies could face fines or have their products seized from store shelves. Gottlieb said the agency was concerned about sweet flavors in several of the products, which he said are “one of the principal drivers of the youth appeal of e-cigarettes.”

POPULAR AMONG TEENS

The FDA has faced increased pressure to act as the sleek Juul e-cigarettes have surged in popularity among U.S. teenagers. Juul Labs Inc's share of the e-cigarette market rose to more than 70 percent now, up from 13.6 percent in early 2017, according to a Wells Fargo analysis of Nielsen retail data that does not include online sales.

Juul sales grew from 2.2 million devices sold in 2016 to 16.2 million devices last year, according to the U.S. Centers for Disease Control and Prevention. Many high schools have resorted to locking bathrooms – jokingly called "Juul rooms" by students.

The Juul design mimics a flash drive - with plug-in cartridges of concentrated nicotine juice. It is far more compact than earlier vaping devices and produces less vapor, making it easy to use without being detected - an attribute some health advocates say attracts teenagers.

Juul was on the market before the August 2016 FDA deadline, but other companies have introduced new copycat devices after the cutoff date without regulatory consequences.

Anti-smoking advocates including the Campaign for Tobacco-Free Kids complained about the Juul lookalikes in an August letter to the FDA, saying the companies that had "evaded the review process."

The FDA has recently cracked down on what it calls an "epidemic" of youth e-cigarette use, threatening last month to ban Juul and four other leading e-cigarette products unless their makers take steps to prevent use by minors.

(Reporting by Chris Kirkham; Editing by Nick Zieminski)

By Chris Kirkham

Stocks mentioned in the article
ChangeLast1st jan.
BRITISH AMERICAN TOBACCO 1.09% 2871.5 Delayed Quote.14.86%
IMPERIAL BRANDS 0.12% 2604 Delayed Quote.9.55%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BRITISH AMERICAN TOBACCO
02/19BRITISH AMERICAN TOBACCO : Uzbekistan named Top Employer 2019
AQ
02/18LONDON STOCK EXCHANGE : FTSE 100 dips as investors book in profits, pound streng..
RE
02/12LONDON MARKETS: London Struggles As Investors Eye U.S. Politics; TUI Under Pr..
DJ
02/11BAT Rekindles Formula One Link as Big Tobacco Fires Up Next-Gen PR Push
DJ
02/11BRITISH AMERICAN TOBACCO : Tobacco giant BAT returns to Formula One with McLaren
RE
02/11BRITISH AMERICAN TOBACCO : partners globally with McLaren
AQ
02/07Japan Tobacco forecasts strong sales amid tepid heat-not-burn products market
RE
02/02PHILIP MORRIS INTERNATIONAL : ‘Cigarettes Sold in Africa More Toxic than T..
AQ
01/31BRITISH AMERICAN TOBACCO : recognised again as a Global Top Employer
AQ
01/31BRITISH AMERICAN TOBACCO : Monthly statement on outstanding equity shares and vo..
CO
More news
Financials (GBP)
Sales 2018 24 345 M
EBIT 2018 10 265 M
Net income 2018 6 308 M
Debt 2018 44 457 M
Yield 2018 6,87%
P/E ratio 2018 9,97
P/E ratio 2019 8,98
EV / Sales 2018 4,53x
EV / Sales 2019 4,22x
Capitalization 65 866 M
Chart BRITISH AMERICAN TOBACCO
Duration : Period :
British American Tobacco Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BRITISH AMERICAN TOBACCO
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 35,1  GBP
Spread / Average Target 22%
EPS Revisions
Managers
NameTitle
Nicandro Durante Chief Executive Officer & Executive Director
Jack Marie Henry David Bowles Chief Executive Officer-Designate & Director
Richard George William Burrows Chairman
Alan Davy Director-Group Operations
John Benedict Stevens Executive Director & Finance Director
Sector and Competitors
1st jan.Capitalization (M$)
BRITISH AMERICAN TOBACCO14.86%85 949
PHILIP MORRIS INTERNATIONAL30.54%135 482
IMPERIAL BRANDS9.55%32 510
SWEDISH MATCH26.41%8 495
PHILIP MORRIS CR, A.S.0.00%1 213
TURNING POINT BRANDS INC49.49%802